Why Informed Consent Is a Clinical and Legal Foundation
Informed consent is more than a signature on a form — it is an ongoing process of patient education and shared decision-making. In hormone therapy, where treatments are often long-term, involve off-label use, and carry potential risks, the quality of your informed consent process directly determines patient outcomes, practice reputation, and medico-legal protection.
The Elements of Valid Informed Consent
Valid informed consent requires: disclosure of the nature of the proposed treatment, the expected benefits and risks, alternative treatment options (including no treatment), and confirmation that the patient has the capacity to understand and decide. In hormone therapy, this means clearly explaining what the hormone therapy is, what physiological changes to expect, potential side effects, monitoring requirements, and what happens if therapy is discontinued.
TRT-Specific Consent Points
For testosterone replacement therapy, informed consent must specifically address: fertility suppression and the need for alternative strategies if future fertility is desired, potential erythrocytosis and cardiovascular implications, PSA changes and prostate monitoring requirements, potential for estradiol elevation and management strategies, the distinction between therapeutic and supraphysiologic dosing, and the fact that TRT is a long-term commitment with withdrawal effects if stopped abruptly.
Off-Label Use Consent
A significant portion of hormone therapy involves off-label use — testosterone in women, progesterone for men, peptides, and certain compounded formulations. Off-label prescribing is legal and common in medicine, but it requires explicit consent. Document that the patient understands the medication is being used for an indication not specifically approved by the FDA, that the evidence base was discussed, and that the clinical rationale was explained.
Compounded Medication Consent
Compounded medications carry additional consent requirements: the medication is not FDA-approved as a finished product, potency and sterility standards may differ from commercial products, and the patient should report any quality concerns. Include the compounding pharmacy name and the specific formulation in your documentation.
Documentation Best Practices
Use structured consent forms specific to each treatment type — not generic consent forms. Have patients sign and date, and provide them with a copy. Document the consent conversation in your SOAP note (“patient was counseled on risks and benefits of TRT including fertility effects, hematocrit monitoring, and PSA surveillance; questions were answered; patient agreed to proceed”). Revisit consent annually or when treatment changes significantly.